These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 32891627)

  • 1. Recovery From Dialysis in Patients With Primary Hyperoxaluria Type 1 Treated With Pyridoxine: A Report of 3 Cases.
    Lorenz EC; Lieske JC; Seide BM; Olson JB; Mehta R; Milliner DS
    Am J Kidney Dis; 2021 May; 77(5):816-819. PubMed ID: 32891627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant.
    Lorenz EC; Lieske JC; Seide BM; Meek AM; Olson JB; Bergstralh EJ; Milliner DS
    Am J Transplant; 2014 Jun; 14(6):1433-8. PubMed ID: 24797341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumasiran for Advanced Primary Hyperoxaluria Type 1: Phase 3 ILLUMINATE-C Trial.
    Michael M; Groothoff JW; Shasha-Lavsky H; Lieske JC; Frishberg Y; Simkova E; Sellier-Leclerc AL; Devresse A; Guebre-Egziabher F; Bakkaloglu SA; Mourani C; Saqan R; Singer R; Willey R; Habtemariam B; Gansner JM; Bhan I; McGregor T; Magen D
    Am J Kidney Dis; 2023 Feb; 81(2):145-155.e1. PubMed ID: 35843439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nocturnal home hemodialysis for a patient with type 1 hyperoxaluria.
    Plumb TJ; Swee ML; Fillaus JA
    Am J Kidney Dis; 2013 Dec; 62(6):1155-9. PubMed ID: 23830800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of urine and plasma oxalate in children with primary hyperoxaluria type 1.
    Sas DJ; Mara K; Mehta RA; Seide BM; Banks CJ; Danese DS; McGregor TL; Lieske JC; Milliner DS
    Pediatr Nephrol; 2024 Jan; 39(1):141-148. PubMed ID: 37458799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical spectrum of primary hyperoxaluria type 1: Experience of a tertiary center.
    Soliman NA; Nabhan MM; Abdelrahman SM; Abdelaziz H; Helmy R; Ghanim K; Bazaraa HM; Badr AM; Tolba OA; Kotb MA; Eweeda KM; Fayez A
    Nephrol Ther; 2017 May; 13(3):176-182. PubMed ID: 28161266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1.
    Garrelfs SF; Frishberg Y; Hulton SA; Koren MJ; O'Riordan WD; Cochat P; Deschênes G; Shasha-Lavsky H; Saland JM; Van't Hoff WG; Fuster DG; Magen D; Moochhala SH; Schalk G; Simkova E; Groothoff JW; Sas DJ; Meliambro KA; Lu J; Sweetser MT; Garg PP; Vaishnaw AK; Gansner JM; McGregor TL; Lieske JC;
    N Engl J Med; 2021 Apr; 384(13):1216-1226. PubMed ID: 33789010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vitamin B6 supplementation on plasma oxalate and oxalate removal rate in hemodialysis patients.
    Costello JF; Sadovnic MC; Smith M; Stolarski C
    J Am Soc Nephrol; 1992 Oct; 3(4):1018-24. PubMed ID: 1450364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma oxalate levels in primary hyperoxaluria type I show significant intra-individual variation and do not correlate with kidney function.
    Hillebrand P; Hoppe B
    Pediatr Nephrol; 2020 Jul; 35(7):1227-1233. PubMed ID: 32274573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxalate balance studies in patients on hemodialysis for type I primary hyperoxaluria.
    Marangella M; Petrarulo M; Cosseddu D; Vitale C; Linari F
    Am J Kidney Dis; 1992 Jun; 19(6):546-53. PubMed ID: 1595703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance and removal of oxalate in children on intensified dialysis for primary hyperoxaluria type 1.
    Illies F; Bonzel KE; Wingen AM; Latta K; Hoyer PF
    Kidney Int; 2006 Nov; 70(9):1642-8. PubMed ID: 16955107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumasiran: A Review in Primary Hyperoxaluria Type 1.
    Kang C
    Drugs; 2024 Feb; 84(2):219-226. PubMed ID: 38252335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral native nephrectomy reduces systemic oxalate level after combined liver-kidney transplant: A case report.
    Villani V; Gupta N; Elias N; Vagefi PA; Markmann JF; Paul E; Traum AZ; Yeh H
    Pediatr Transplant; 2017 May; 21(3):. PubMed ID: 28261895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival on renal replacement therapy for primary hyperoxaluria type I.
    Calzavara P; Marangella M; Petrarulo M; Ballanti P; Bonucci E; Calconi G; Maresca MC; da Porto A; Vianello A
    Nephron; 1993; 63(2):217-21. PubMed ID: 8450916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a Phase II study.
    Hoppe B; Pellikka PA; Dehmel B; Banos A; Lindner E; Herberg U
    Nephrol Dial Transplant; 2021 Jul; 36(8):1464-1473. PubMed ID: 32810261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of primary hyperoxaluria type 1.
    Gupta A; Somers MJG; Baum MA
    Clin Kidney J; 2022 May; 15(Suppl 1):i9-i13. PubMed ID: 35592620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.
    Oppici E; Fargue S; Reid ES; Mills PB; Clayton PT; Danpure CJ; Cellini B
    Hum Mol Genet; 2015 Oct; 24(19):5500-11. PubMed ID: 26199318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 1 primary hyperoxaluria: A case report and focus on bone impairment of systemic oxalosis.
    Pijnenburg L; Caillard S; Boivin G; Rizzo S; Javier RM
    Morphologie; 2018 Mar; 102(336):48-53. PubMed ID: 29102553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma calcium oxalate supersaturation in children with primary hyperoxaluria and end-stage renal failure.
    Hoppe B; Kemper MJ; Bökenkamp A; Portale AA; Cohn RA; Langman CB
    Kidney Int; 1999 Jul; 56(1):268-74. PubMed ID: 10411702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.